EDIT - CIK 0001650664
The table below shows Editas Medicine, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $123.65M | $165.65M | $138.54M | $138.69M | $95.83M | $64.44M |
| Short-term investments | - | $0.00 | $39.96M | $82.27M | $169.26M | $214.67M |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $128.07M |
| $176.89M |
| $182.80M |
| $224.84M |
| $271.14M |
| $286.35M |
| Property, plant & equipment | $2.88M | $4.29M | $4.58M | $8.18M | $15.42M | $14.16M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $149.34M | $201.75M | $210.58M | $263.65M | $327.57M | $384.80M |
| Accounts payable | $4.33M | $3.16M | $6.72M | $5.46M | $12.49M | $13.77M |
| Total current liabilities | $39.78M | $61.77M | $65.94M | $73.11M | $72.35M | $74.31M |
| Long-term debt | $47.18M | $54.07M | $51.67M | $49.58M | - | - |
| Total liabilities | $144.93M | $188.30M | $191.39M | $201.23M | $151.93M | $152.79M |
| Retained earnings | -$1.65B | -$1.62B | -$1.60B | -$1.54B | -$1.42B | -$1.36B |
| Total equity | $4.41M | $13.45M | $19.19M | $62.42M | $175.63M | $232.01M |